Exercise and Nose Spray Insulin for Type 2 Diabetes

Exercise and Intranasal Insulin in Type 2 Diabetes

Recruiting Phase 2 Phase 3 Interventional Study
Type 2 Diabetes Insulin Sensitivity/Resistance Cognition Brain Blood Flow
Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 – 80
Sex
Any
Trial phase
Phase 2/3
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Rutgers, The State University of New Jersey · Other
Who this trial is looking for

This trial is looking for adults aged 55 to 80 with type 2 diabetes. Participants will engage in regular exercise and use a nose spray that contains insulin to see how it affects thinking and memory.

Are You a Good Fit for This Trial?
Must be taking MetforminGLP-1 agonistsTZDsDPP-IV inhibitorsAcarboseSGLT-2 inhibitors
Rules you out DementiaParkinson's diseaseHypertriglyceridemiaHypercholesterolemiaPregnancyMajor psychiatric disorders

You may be able to join if

  • I am between 55 and 80 years old.
  • I have been diagnosed with type 2 diabetes.
  • I have been taking diabetes medication for more than 6 months.
  • I have a MOCA score of 26 or higher.
  • My body mass index (BMI) is between 25 and 40.
  • I do not have type 1 diabetes.
  • I currently exercise less than 90 minutes a week.

You may not be able to join if

  • I have a diagnosis of dementia.
  • I have a neurological disease.
  • I cannot tolerate insulin.
  • I have had a significant weight change in the last 6 months.
  • I have smoked or quit smoking in the last 2 years.
  • I have uncontrolled high blood pressure.
  • I have a history of significant medical issues that could affect my safety.
  • I have had significant anxiety in closed spaces.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
About 6.5 million adults in the United States who are 65 or older have dementia. While the exact cause of dementia is not known, it may be due to changes in the brain. Further, risk may be higher when the brain does not respond to insulin. Indeed, brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic e…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male or female 55-80 years old * Type 2 diabetes diagnosis or confirmation HbA1c \>6.5% and fasting glucose \>126 mg/dl * Individuals prescribed metformin, GLP-1 agonists (oral/injectable), TZDs, DPP-IV inhibitors, Acarbose, SGLT-2 inhibitors \>6 months. * MOCA ≥26 * Body mass…
Contacts

Steven K Malin, PhD

848-932-7540

steven.malin@rutgers.edu

CONTACT

Emily M Heiston, PhD

848-932-7540

emily.heiston@rutgers.edu

CONTACT